Benefit-Risk SIG

The Benefit-Risk SIG was set up at the start of 2012 to help support those involved in this fast evolving area.

The main aims of the SIG are:

  • To understand how best to apply Benefit-Risk methodologies across the Pharmaceutical Industry
  • To discuss and make recommendations on key methodological issues
  • To share examples of how Benefit-Risk has been used within pharmaceutical companies
  • To share external information including new developments around Benefit-Risk

Currently the SIG has subgroups working on:

  • Literature review
  • Benefit-Risk in the HTA setting (together with the HTA SIG)
  • Bayesian applications in Benefit-Risk
  • Preference elicitation and  Benefit-Risk

We also develop relevant training in the area of structured  Benefit-Risk as needed.

If you have an interest in being involved in this SIG, or have an interesting case study or experience of carrying out a structured Benefit-Risk assessment to share, please contact Maria Costa (email:

Our BLOG can be found under It is a great source of information for all things Benefit-Risk related: upcoming conferences, journal publications, training, and much more.

Upcoming Events

Latest Jobs